Form 4: Algorhythm Director Receives Equity, Form 4 Filed Late

Algorhythm Holdings Director Bernardo Melo was granted restricted stock and stock options, with the Form 4 filing occurring significantly after the transaction date.

Summary

• Director Bernardo Melo of Algorhythm Holdings, Inc. (RIME) received a restricted stock award (RSA) of 19,532 shares of common stock on November 20, 2025.
• Melo also received a non-qualified stock option to purchase 39,063 shares of common stock at an exercise price of $1.28 per share on November 20, 2025.
• Both the RSA and the stock option were granted under the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan.
• The RSA and stock option shares vest in equal quarterly installments over a period of one year from the grant date.
• The stock option has an expiration date of November 20, 2035.
• The Form 4 disclosing these transactions was filed on March 30, 2026, significantly after the transaction date of November 20, 2025.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as moderately positive due to the alignment of director and shareholder interests through equity grants, but tempered by the negative implications of a significantly delayed SEC filing, which raises compliance concerns.

Positives

• The grants align Director Bernardo Melo's interests with those of shareholders through equity ownership.
• The equity awards are part of the company's 2022 Equity Incentive Plan, indicating a structured approach to executive compensation and retention.

Negatives

• The Form 4 was filed on March 30, 2026, for transactions that occurred on November 20, 2025, representing a significant delay in reporting insider transactions as required by SEC regulations.

Risks

• The late filing of the Form 4 indicates a potential lapse in internal controls or compliance procedures regarding timely SEC disclosures.
• Failure to comply with SEC filing deadlines can lead to regulatory scrutiny, fines, and reputational damage.
• The vesting of the restricted stock and stock options is contingent on continued service over one year, meaning the director must remain with the company to fully realize the awards.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on an insider's equity transactions.

Industry Context

StockSavvy.ai notes that the granting of restricted stock and stock options to directors is a common practice across industries to incentivize long-term commitment and align leadership interests with shareholder value. However, the significant delay in filing this Form 4 is a deviation from standard compliance practices, which typically require such disclosures within two business days of the transaction.

Comparison to Industry Standards

• Equity grants to directors, such as restricted stock and stock options, are standard compensation tools used by publicly traded companies across various sectors, including technology and software, to attract and retain talent and align interests. For example, similar grants are seen at companies like Palantir Technologies (PLTR) or C3.ai (AI) for their board members.
• The vesting schedule of one year in quarterly installments is a common short-to-medium term incentive structure, comparable to many peer companies' equity compensation plans.
• The late filing of a Form 4, however, falls below industry best practices and SEC compliance standards, which mandate timely disclosure of insider transactions. Companies like Microsoft (MSFT) or Apple (AAPL) maintain rigorous internal controls to ensure Form 4 filings are made within the two-business-day window.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grants aim to align the director's long-term interests with shareholder value creation. However, the late filing could raise concerns about corporate governance and transparency.
• Regulatory Authorities: The delayed filing may attract scrutiny from the SEC regarding compliance with Section 16(a) reporting requirements.

Next Steps

• The restricted stock and stock options will vest in equal quarterly installments over one year from the grant date of November 20, 2025.

Key Dates

Keywords

Algorhythm Holdings, RIME, Bernardo Melo, Form 4, Insider Transaction, Restricted Stock Award, Stock Option, Equity Incentive Plan, Director Compensation, SEC Filing